Revista Panamericana de Salud Pública
Print version ISSN 1020-4989
ALMEIDA, Stella Pereira; BIZETO, Juliana and SILVA, Maria Teresa Araujo. Analysis of spontaneous comments posted by ecstasy users participating in an online survey. Rev Panam Salud Publica [online]. 2007, vol.22, n.6, pp. 389-395. ISSN 1020-4989. http://dx.doi.org/10.1590/S1020-49892007001100004.
OBJECTIVE: To analyze the contents of spontaneous comments posted by ecstasy users participating in an online survey that constitutes phase one of a harm reduction project (projeto Baladaboa) aimed at users of this drug. METHOD: Of the 1 140 individual respondents, 412 posted unprompted comments. These comments were grouped into five categories (irrelevant, drugs, testimonies, survey, and project) and submitted to content analysis. Salutations, irreverent comments, and ideological remarks were considered "Irrelevant." Comments on the causes, effects, and consequences of using ecstasy or other drugs; requests for information on the drug; or comments indicating that information is a crucial issue associated with the use of ecstasy were labeled "Drugs." Personal stories made up the group called "Testimonies." Any comments concerning the questionnaire itself, the formulation of questions, the use of certain criteria, and requests to see survey results were designated "Survey." Comments specifically about the Baladaboa project were categorized as "Project." RESULTS: Content analysis revealed 915 segments among the 412 comments. The percent distribution of segments among the groups were: irrelevant, 9.8%; drugs, 16.4%; testimonies, 18.1%; survey, 25.1%; and project, 30.6%. Most of the comments concerning the survey and the project were positive. CONCLUSIONS: The number and content of the spontaneous comments indicate that the project, as well as the harm reduction strategy, were being well received by the target audience. The participants expressed their engagement with the project and suggested that its continuation is both timely and urgent.
Keywords : N-methyl-3; 4-methylenedioxyamphetamine; psychotropic drugs; harm reduction; Brazil.